Clinical Trial: Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopath

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectiv

Brief Summary: To evaluate the efficacy of Sodium Thiosulfate (STS) compared to placebo, in reducing analgesic requirement in subjects with calcific uremic arteriolopathy (CUA) during an initial 28-day treatment phase.

Detailed Summary: Efficacy of Sodium Thiosulfate (STS) compared to placebo, in reducing analgesic requirement in subjects with calcific uremic arteriolopathy (CUA) during an initial 28-day treatment phase.
Sponsor: Luitpold Pharmaceuticals

Current Primary Outcome: Reduction in Analgesic Requirement [ Time Frame: up to 28 Days ]

The length of time in days, from first treatment with blinded study drug; to when subject requires rescue analgesic


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Luitpold Pharmaceuticals

Dates:
Date Received: August 17, 2015
Date Started: January 30, 2015
Date Completion:
Last Updated: January 19, 2017
Last Verified: January 2017